PMCID: PMC7540535 ) Elashoff M, Matveyenko AV, Gier B, Elashoff R, Butler PC (2011) Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies
455.08/Q4 2012 Neuroscience Meeting Planner
DOI: 10.1007/s11515-012-1218-y REFERENCES National Center for Biotechnology Information
Inform patients of the signs and symptoms of acute kidney injury and instruct them to promptly report any of these signs or symptoms or persistent (or extended) nausea, vomiting, and diarrhea to their healthcare provider [see Warnings and Precautions (5.5)]
GLP-1 receptor agonists like semaglutide (Wegovy) and liraglutide (Saxenda) use fine-gauge needles (31G32G) that are thinner than standard injection needles, reducing tissue trauma and pain